Search

Category

Assay menu for molecular testing

alt

Respiratory

Influenza A/B + RSV

SARS-CoV-2 + Influenza A/B^***

Antimicrobial stewardship

cobas^® Liat^® Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.

alt

Infectious Diseases

Transplant

Genomics and oncology

Factor II/V

Sexual Health

Antimicrobial stewardship

MG Resistance^**

GC Resistance^**

User defined functionality (UDF)

cobas^® 4800 System Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.

cobas 6800 icon

Donor Screening

Malaria^*

Infectious Diseases

HSV-1/2/VZV^†##

Sexual Health

Respiratory

Influenza A/B + RSV^†##

SARS-CoV-2 + Influenza A/B^***

SARS-CoV-2 Variant^†

Influenza A/B + RSV^*#

Parainfluenza 1-4^*

ADV, hMPV, EV/RV^*

MPLX Respiratory^*

Transplant

HSV-1/2/VZV^**#

Antimicrobial stewardship

MG Resistance^*

GC Resistance^*

cobas omni Utility Channel for third-party tests and LDTs

cobas^® 6800/8800 System Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.

LightMix^{^®} Modular assays^‡ for the Lightcycler^{^®} 480 & cobas z 480 Instruments

alt

Gastro Parasite Panel

Giardia^CE

Dientamoeba fragilis^CE

Cryptosporidium spp^CE

Blastocystis^CE

Entamoeba histolitica^CE

Gastro Virus Panel

Novovirus GG1^CE

Novovirus GG2^CE

Sapovirus^CE

Rotavirus^CE

Adenovirus^CE

Astrovirus^CE

Gastro Bacteria Panel

Aeromonas^CE

Yersinia enterocolitica^CE

Campylobacter^CE

Shigella/EIEC^CE

Salmonella^CE

Plesiomonas

Emerging Pathogens Panel

Zika Virus^CE

Respiratory Influenza Panel

Influenza A^CE

Influenza B^CE

Influenza A H1 (H1N1)^CE

Influenza A H3

Influenza A H5

Influenza A H7 (H7N9)

Influenza A H9

Respiratory Virus Panel

RSV^CE

ParaInfluenza 1^CE

ParaInfluenza 2^CE

ParaInfluenza 3^CE

ParaInfluenza 4^CE

Enterovirus^CE

Bocavirus^CE

Parechovirus^CE

Metapneumovirus^CE

Adenovirus^CE

Picornavirus^CE

Rhinovirus

Respiratory Coronavirus Panel

Sarbecovirus SARS-CoV-2^CE

SARS-CoV-2 (COVID 19) N-gene

SARS-CoV-2 (COVID 19) E-gene

SARS-CoV-2 (COVID 19) RdRP-gene

MERS Coronavirus UpE

MERS Coronavirus Orf1a

Coronavirus HKU1

Coronavirus OC43

Coronavirus 229E

Coronavirus NL63

panCoronavirus

Respiratory Bacteria Panel

Bordetella pertussis

Bordetella parapertussis

Respiratory Atypical pneumonia Panel

Pneumocystis jirovecii

Mycoplasma pneumoniae

Chlamydophila psittaci

Chlamydia pneumoniae

Legionella pneumophila

Legionella spp/pn

Carbapenemase Panel

KPC^CE

OXA-23^CE

GES^CE

VIM^CE

NDM^CE

OXA-48^CE

IMP^CE

EHEC Panel

STX1-EHEC

STX2-EHEC

EAE-EHEC

New Born Panel

TREC

KREC

Non-Culturable Panel

T. whipplei

Filovirus Panel

Ebola Zaire

Tropical Panel

Zika

Dengue

Chikungunya

Plasmodium genus

Bacterial Meningitis Panel

Escherichia coli uidA

Listeria monocytogenes

Streptococcus pneumoniae

Neisseria meningitidis

Streptococcus agalactiae

Haemophilus influenzae

Resistance Panel

MCR-1

LightMix® Modular Assays manufactured by TIB MOLbiol and exclusively distributed by Roche.

TIB MOLBIOL assays are for Life Science Research (LSR) - not for use in diagnostic procedures. Some assays are also CE-marked as indicated.

*	In development
**	Not available in the US
***	Emergency Use Authorization (EUA) & CE-IVD
†	Research use only (RUO); not for use in diagnostic procedures
‡	Life Science Research (LSR); not for use in diagnostic procedures
#	cobas omni Utility Channel CE-IVD
##	cobas omni Utility Channel Primer/Probe Set
§	HIV-1 can be run with plasma on the cobas® Plasma Separation Card for viral load quantification and with Dried Blood Spots as a qualitative test
∥	Self-sampling in development
CE	Available in countries accepting CE-mark

Assays are not available in all markets; check with your local Roche affiliate about availability and registration status in your area.

Key diagnostic areas

Our assay portfolio spans across a wide range of diseases. Explore our key diagnostic fields below.

Donor Screening

Confidently screen donated blood for infectious diseases with market-leading serology and nucleic acid testing. See how Roche’s industry-leading analyzers and IT solutions deliver never-before-achieved throughput and automation.

infectious diseases

Infectious Diseases

The infectious diseases portfolio from Roche is expanding every year. We are not only focusing on launching new parameters but we are also continuously updating our existing portfolio seeking continuous improvement.

Roche Diagnostics oncology health topics

Roche diagnostics' offering for gynecology includes tests in the area of fertility, pregnancy, prenatal care, and HPV and STI screening.

Roche delivers solutions that providers need, from fertility to prenatal care, cervical and STI screening, breast and ovarian cancer, bone health and more.

Related products